SKI Market

Indian Indices

Nifty

22,419.95 -150.40
(-0.67%)

Sensex

73,730.16 -609.28
( -0.82%)

Bank Nifty

48,201.05 -293.90
( -0.61%)

Nifty IT

33,666.25 111.85
( 0.33%)

Global Indices

Nasdaq

15,927.90 316.14
(2.03%)

Dow Jones

38,239.66 153.86
(0.40%)

Hang Seng

17,651.15 366.61
(2.12%)

Nikkei 225

37,934.76 306.28
(0.81%)

Forex

USD-INR

83.32 0.01
(0.01%)

EUR-INR

89.30 0.19
(0.22%)

GBP-INR

104.10 0.39
(0.38%)

JPY-INR

0.54 0.00
(-0.34%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Par Drugs & Chemicals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

535341

INE04LG01015

63.8765226

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PAR

22.92

325.95

EPS(TTM)

Face Value()

Div & Yield %

11.56

Back

Swasti Vinayaka Synthetics standalone net profit rises 59.52% in the December 2023 quarter

Feb 14,2024

Net profit of Swasti Vinayaka Synthetics rose 59.52% to Rs 0.67 crore in the quarter ended December 2023 as against Rs 0.42 crore during the previous quarter ended December 2022. Sales rose 98.17% to Rs 10.80 crore in the quarter ended December 2023 as against Rs 5.45 crore during the previous quarter ended December 2022.

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	10.80	5.45	98
OPM %	8.61	11.01	-
PBDT	0.76	0.50	52
PBT	0.67	0.42	60
NP	0.67	0.42	60

22,419.95 -150.40 (-0.67%)

73,730.16 -609.28 ( -0.82%)

48,201.05 -293.90 ( -0.61%)

33,666.25 111.85 ( 0.33%)

15,927.90 316.14 (2.03%)

38,239.66 153.86 (0.40%)

17,651.15 366.61 (2.12%)

37,934.76 306.28 (0.81%)

83.32 0.01 (0.01%)

89.30 0.19 (0.22%)

104.10 0.39 (0.38%)

0.54 0.00 (-0.34%)